Profile for Proteostasis Therapeutics Inc. (PTI)

$ 4.25   0.15 (+3.66%) Volume: 4.17m 4:00 PM EST Dec 13, 2019
After Hours:  $ 4.40   0.15 (+3.53%) Volume: 98.37k 7:59 PM EST Dec 13, 2019
Business Description:
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Address: 80 Guest Street, Suite 500, 5th Floor, Boston, MA, USA, 02135
Telephone: +1 617 225-0096 Website:
Facsimile: N/A Email: N/A
CEO: Meenu Chhabra
Employees: 49 Market Cap: 217.3m
Issue Type: CS
Auditor: PricewaterhouseCoopers LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1445283
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Biological Products, Except Diagnostic Substances (2836)